Axa
ADTN icon

Axa’s Adtran ADTN Stock Holding History

Axa’s Portfolio ADTN Stock Details ADTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-39,500
Closed -$424K – 1310
2018
Q4 		$424K Buy
+39,500
New +$538K ﹤0.01% 1119

Other funds holding ADTN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Axa's ADTN Position: Q1 2019 in Review

Axa sold out of Adtran (ADTN) in Q1 2019, closing a stake of 39,500 shares — an estimated $424K sold.

Axa first reported a position in ADTN in Q4 2018 and held it in 1 quarter. The position peaked at $424K in Q4 2018. 163 funds tracked by Wall St. Rank hold ADTN as of Q1 2019.

  • Axa reported no remaining Adtran position as of Q1 2019 after selling out during the quarter.
  • Axa sold 39,500 Adtran shares in Q1 2019, an estimated $424K.
  • Axa first reported a position in Adtran in Q4 2018 and held it in 1 quarter.
  • Axa's Adtran position peaked at $424K in Q4 2018.
  • 163 funds tracked by Wall St. Rank held Adtran as of Q1 2019.

Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.